Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2019 Jan 1.

Published in final edited form as: Hum Psychopharmacol. 2017 Dec 21;33(1):10.1002/hup.2645. doi: 10.1002/hup.2645

TABLE 1.

Group differences in sociodemographics, syndemic burden, and neuroendocrine functioning (N = 309)

	METH-HIV− (n = 136)	METH + HIV+ (n = 127)	METH + HIV− (n = 46)
	n (%)	n (%)	n (%)
Race/ethnicity	12 (9)			χ² (6) = 18.24, p = .006
Caucasian	38 (28)	34 (27)	13 (28)
African American	79 (58)	33 (26)	9 (20)
Hispanic/Latino	7 (5)	56 (44)	21 (46)
Body mass index (BMI)				χ² (4) = 23.47, p < .001
Normal	34 (25)	60 (48)	25 (54)
Overweight	58 (43)	47 (37)	14 (31)
Obese	44 (32)	19 (15)	7 (15)
>3 Syndemic conditions	1 (1)^a,^b	79 (62)^a,^c	20 (44)^b,^c	χ² (2) = 116.42, p < .001
	M (SD)	M (SD)	M (SD)
Age	35.26 (10.45)^a	39.85 (8.39)^a,^c	33.22 (9.50)^c	F(2, 306) = 11.59, p < .001
Log₁₀ HOMA-IR	0.51 (0.30)^a,^b	0.34 (0.30)^a	0.28 (0.35)^b	F(2, 306) = 13.96, p < .001
Log₁₀ ACTH	1.30 (0.29)	1.31 (0.37)	1.37 (0.21)	F(2, 306) = 0.87, p = .42
Log₁₀ cortisol	1.99 (0.15)	2.03 (0.19)	2.04 (0.19)	F(2, 306) = 2.72, p = .07

^a

METH-HIV− versus METH + HIV+, p < .05.

^b

METH-HIV− vs METH + HIV−, p < .05.

^c

METH + HIV+ versus METH + HIV−, p < .05.